<DOC>
	<DOC>NCT02858219</DOC>
	<brief_summary>The main objective of this study is to compare the efficacy of botulinum toxin injections on vestibulodynia pain compared to a group treated with a placebo.</brief_summary>
	<brief_title>A Pilot Study of the Effects of Botulinum Toxin in the Treatment of Provoked Vestibulodynia</brief_title>
	<detailed_description />
	<mesh_term>Vulvodynia</mesh_term>
	<mesh_term>Vulvar Vestibulitis</mesh_term>
	<mesh_term>Pharmaceutical Solutions</mesh_term>
	<mesh_term>Botulinum Toxins, Type A</mesh_term>
	<mesh_term>incobotulinumtoxinA</mesh_term>
	<mesh_term>abobotulinumtoxinA</mesh_term>
	<mesh_term>onabotulinumtoxinA</mesh_term>
	<mesh_term>Botulinum Toxins</mesh_term>
	<criteria>Subject refractory to conventional treatments (tricyclic antidepressants and benzodiazepines at analgesic doses, biofeedback physical therapy) Negative screening test results Notified associated factors Menopause, surgically sterilized women or women using effective contraceptive method Good understanding and predictable adherence to the protocol beneficiary/affiliated to French social security/social healthcare signed Informed Consent Form Predictable poor adherence Pregnant or breastfeeding women Myasthenia Treatment with aminoglycosides Major mental disorders Underlying etiology Vulnerable subjects (particularly adults under guardianship) Any reason deemed relevant by the investigator Current or former (in the last 3 months) participation to another clinical trial</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>July 2016</verification_date>
	<keyword>Botulinum toxin</keyword>
	<keyword>Pain improvement</keyword>
</DOC>